Subcutaneous ketamine infusion in palliative patients for major depressive disorder (SKIPMDD)—Phase II single-arm open-label feasibility study

by Wei Lee, Caitlin Sheehan, Richard Chye, Sungwon Chang, Adam Bayes, Colleen Loo, Brian Draper, Meera R. Agar, David C. Currow
Published 2023-01-01

Subcutaneous ketamine infusion in palliative patients for major depressive disorder (SKIPMDD)-Phase II single-arm open-label feasibility study.

by Wei Lee, Caitlin Sheehan, Richard Chye, Sungwon Chang, Adam Bayes, Colleen Loo, Brian Draper, Meera R Agar, David C Currow
Published 2023-01-01